Cargando…

Silodosin Inhibits Noradrenaline-Activated Transcription Factors Elk1 and SRF in Human Prostate Smooth Muscle

BACKGROUND: The transcription factors Elk1 and serum response factor (SRF) are central regulators of cell cycle and phenotype in various cell types. Elk1 is activated by phosphorylation (serine-383), while activation of SRF requires its co-factor, myocardin. Activation of Elk1 and SRF results in bin...

Descripción completa

Detalles Bibliográficos
Autores principales: Hennenberg, Martin, Strittmatter, Frank, Beckmann, Christer, Rutz, Beata, Füllhase, Claudius, Waidelich, Raphaela, Montorsi, Francesco, Hedlund, Petter, Andersson, Karl-Erik, Stief, Christian G., Gratzke, Christian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3511420/
https://www.ncbi.nlm.nih.gov/pubmed/23226423
http://dx.doi.org/10.1371/journal.pone.0050904
_version_ 1782251604469088256
author Hennenberg, Martin
Strittmatter, Frank
Beckmann, Christer
Rutz, Beata
Füllhase, Claudius
Waidelich, Raphaela
Montorsi, Francesco
Hedlund, Petter
Andersson, Karl-Erik
Stief, Christian G.
Gratzke, Christian
author_facet Hennenberg, Martin
Strittmatter, Frank
Beckmann, Christer
Rutz, Beata
Füllhase, Claudius
Waidelich, Raphaela
Montorsi, Francesco
Hedlund, Petter
Andersson, Karl-Erik
Stief, Christian G.
Gratzke, Christian
author_sort Hennenberg, Martin
collection PubMed
description BACKGROUND: The transcription factors Elk1 and serum response factor (SRF) are central regulators of cell cycle and phenotype in various cell types. Elk1 is activated by phosphorylation (serine-383), while activation of SRF requires its co-factor, myocardin. Activation of Elk1 and SRF results in binding to specific DNA sequences in promoter regions, and may be induced by adrenergic receptor activation in different organs. OBJECTIVE: To examine the effects of adrenergic stimulation on Elk1 and SRF in the human prostate and the ability of the highly selective α1A-adrenoceptor antagonist, silodosin, on transcription factor activation. METHODS: Prostate tissue was obtained from patients undergoing radical prostatectomy. Expression of Elk1, SRF, and myocardin was estimated by Western blot and immunohistochemistry. Colocalizations were studied by double immunofluorescence staining. Noradrenaline- (NA-) and phenylephrine- (PE-) induced phosphorylation of Elk1 was assessed by Western blot analysis using a phospho-specific antibody. NA-induced activation of Elk1 and SRF was investigated by electrophoretic mobility shift assay (EMSA). RESULTS: Immunoreactivity for Elk1, SRF, and myocardin was observed in stromal cells of tissues from each patient. In fluorescence stainings, SRF colocalized with myocardin and α-smooth muscle actin (αSMA). Stimulation of prostate tissues with PE (10 µM) or NA (30 µM) increased the phosphorylation of Elk1 at serine-383. NA-induced Elk1 activation was confirmed by EMSA, where a NA-induced binding of Elk1 to the DNA sequence TTTGCAAAATGCAGGAATTGTTTTCACAGT was observed. Similarly, NA caused SRF binding to the SRF-specific DNA sequence CCATATTAGGCCATATTAGG. Application of silodosin (3 µM) to prostate tissues reduced the activity of Elk1 and SRF in NA-stimulated tissues. CONCLUSIONS: Silodosin blocks the activation of the two transcription factors, Elk1 and SRF, which is induced by noradrenaline in the human prostate. A role of α1-adrenoceptors beyond smooth muscle contraction may be considered, which includes a function in transcriptional regulation.
format Online
Article
Text
id pubmed-3511420
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-35114202012-12-05 Silodosin Inhibits Noradrenaline-Activated Transcription Factors Elk1 and SRF in Human Prostate Smooth Muscle Hennenberg, Martin Strittmatter, Frank Beckmann, Christer Rutz, Beata Füllhase, Claudius Waidelich, Raphaela Montorsi, Francesco Hedlund, Petter Andersson, Karl-Erik Stief, Christian G. Gratzke, Christian PLoS One Research Article BACKGROUND: The transcription factors Elk1 and serum response factor (SRF) are central regulators of cell cycle and phenotype in various cell types. Elk1 is activated by phosphorylation (serine-383), while activation of SRF requires its co-factor, myocardin. Activation of Elk1 and SRF results in binding to specific DNA sequences in promoter regions, and may be induced by adrenergic receptor activation in different organs. OBJECTIVE: To examine the effects of adrenergic stimulation on Elk1 and SRF in the human prostate and the ability of the highly selective α1A-adrenoceptor antagonist, silodosin, on transcription factor activation. METHODS: Prostate tissue was obtained from patients undergoing radical prostatectomy. Expression of Elk1, SRF, and myocardin was estimated by Western blot and immunohistochemistry. Colocalizations were studied by double immunofluorescence staining. Noradrenaline- (NA-) and phenylephrine- (PE-) induced phosphorylation of Elk1 was assessed by Western blot analysis using a phospho-specific antibody. NA-induced activation of Elk1 and SRF was investigated by electrophoretic mobility shift assay (EMSA). RESULTS: Immunoreactivity for Elk1, SRF, and myocardin was observed in stromal cells of tissues from each patient. In fluorescence stainings, SRF colocalized with myocardin and α-smooth muscle actin (αSMA). Stimulation of prostate tissues with PE (10 µM) or NA (30 µM) increased the phosphorylation of Elk1 at serine-383. NA-induced Elk1 activation was confirmed by EMSA, where a NA-induced binding of Elk1 to the DNA sequence TTTGCAAAATGCAGGAATTGTTTTCACAGT was observed. Similarly, NA caused SRF binding to the SRF-specific DNA sequence CCATATTAGGCCATATTAGG. Application of silodosin (3 µM) to prostate tissues reduced the activity of Elk1 and SRF in NA-stimulated tissues. CONCLUSIONS: Silodosin blocks the activation of the two transcription factors, Elk1 and SRF, which is induced by noradrenaline in the human prostate. A role of α1-adrenoceptors beyond smooth muscle contraction may be considered, which includes a function in transcriptional regulation. Public Library of Science 2012-11-30 /pmc/articles/PMC3511420/ /pubmed/23226423 http://dx.doi.org/10.1371/journal.pone.0050904 Text en © 2012 Hennenberg et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Hennenberg, Martin
Strittmatter, Frank
Beckmann, Christer
Rutz, Beata
Füllhase, Claudius
Waidelich, Raphaela
Montorsi, Francesco
Hedlund, Petter
Andersson, Karl-Erik
Stief, Christian G.
Gratzke, Christian
Silodosin Inhibits Noradrenaline-Activated Transcription Factors Elk1 and SRF in Human Prostate Smooth Muscle
title Silodosin Inhibits Noradrenaline-Activated Transcription Factors Elk1 and SRF in Human Prostate Smooth Muscle
title_full Silodosin Inhibits Noradrenaline-Activated Transcription Factors Elk1 and SRF in Human Prostate Smooth Muscle
title_fullStr Silodosin Inhibits Noradrenaline-Activated Transcription Factors Elk1 and SRF in Human Prostate Smooth Muscle
title_full_unstemmed Silodosin Inhibits Noradrenaline-Activated Transcription Factors Elk1 and SRF in Human Prostate Smooth Muscle
title_short Silodosin Inhibits Noradrenaline-Activated Transcription Factors Elk1 and SRF in Human Prostate Smooth Muscle
title_sort silodosin inhibits noradrenaline-activated transcription factors elk1 and srf in human prostate smooth muscle
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3511420/
https://www.ncbi.nlm.nih.gov/pubmed/23226423
http://dx.doi.org/10.1371/journal.pone.0050904
work_keys_str_mv AT hennenbergmartin silodosininhibitsnoradrenalineactivatedtranscriptionfactorselk1andsrfinhumanprostatesmoothmuscle
AT strittmatterfrank silodosininhibitsnoradrenalineactivatedtranscriptionfactorselk1andsrfinhumanprostatesmoothmuscle
AT beckmannchrister silodosininhibitsnoradrenalineactivatedtranscriptionfactorselk1andsrfinhumanprostatesmoothmuscle
AT rutzbeata silodosininhibitsnoradrenalineactivatedtranscriptionfactorselk1andsrfinhumanprostatesmoothmuscle
AT fullhaseclaudius silodosininhibitsnoradrenalineactivatedtranscriptionfactorselk1andsrfinhumanprostatesmoothmuscle
AT waidelichraphaela silodosininhibitsnoradrenalineactivatedtranscriptionfactorselk1andsrfinhumanprostatesmoothmuscle
AT montorsifrancesco silodosininhibitsnoradrenalineactivatedtranscriptionfactorselk1andsrfinhumanprostatesmoothmuscle
AT hedlundpetter silodosininhibitsnoradrenalineactivatedtranscriptionfactorselk1andsrfinhumanprostatesmoothmuscle
AT anderssonkarlerik silodosininhibitsnoradrenalineactivatedtranscriptionfactorselk1andsrfinhumanprostatesmoothmuscle
AT stiefchristiang silodosininhibitsnoradrenalineactivatedtranscriptionfactorselk1andsrfinhumanprostatesmoothmuscle
AT gratzkechristian silodosininhibitsnoradrenalineactivatedtranscriptionfactorselk1andsrfinhumanprostatesmoothmuscle